Benzinga

Benzinga

Benzinga

sabato, agosto 29

Pediatrix Medical Group Inc

MDNYSE
Trade with Public
Trade with Public
$26.61
-0.19-0.71%
In chiusura: Aug 28, 5:00 PM EST
$26.61
N/A
Post-mercato: 4:00 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Pediatrix Medical Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Pediatrix Medical Group (MD).

Price Target Range — 12 Quarters

Analyst Consensus — 7 Analysts

1Buy
6Hold
Consensus RatingHold# Analysts7Avg. Consensus PT$20Upside to Avg. PT-24.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026JefferiesJack SlevinDowngradeBuy→Hold$27→$28
Aug 6, 2026UBSA.J. RicePT RaiseNeutral$25→$28
More with Benzinga EdgeGet Access

Analyst Ratings News

This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.
Avi Kapoor

PRO
Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $22 to $25.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $23

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $21 to $23.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved